Financials

News Ideas Discussions Technicals Seasonals

SPRINT fundamentals

Overview Statements Statistics Dividends Earnings Revenue

Key facts

—

—

—

—

—

—

—

—

About

Sprint Bioscience AB is a pharmaceutical company, which engages in the research and development of drug for cancer. It offers product which focuses on the tumor metabolism, diabetes, and non-alcoholic steatohepatitis. The company was founded by Anders Aberg, Par Nordlund, Martin Andersson, Jessica Martinsson, and Kenth Hallberg in 2009 and is headquartered in Huddinge, Sweden.

Valuation

Fundamental metrics to determine fair value of the stock

Summary

No data available

There's currently no market capitalization, revenue or net income data to show.

Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

SPRINT does not pay dividends

The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company